Ignite Creation Date:
2024-05-06 @ 1:35 AM
Last Modification Date:
2024-10-26 @ 11:06 AM
Study NCT ID:
NCT01849328
Status:
UNKNOWN
Last Update Posted:
2013-11-19
First Post:
2013-05-03
Brief Title:
Testing Spectrosense EVA System for Detection of Breast Cancer by Analyzing Volatile Organic Compounds VOCs in Exhaled Air
Sponsor:
Rauscher Gregory E MD PA
Organization:
Rauscher Gregory E MD PA
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2013-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Volatile Organic Compounds VOC in human breath are captured and analyzed by the Spectrosense EVA system which is combination of a gas chromatography GC and software algorithm The objective is to obtain a set or sets of VOC bio-markers that will provide the best discrimination between Breast Cancer sick population and healthy population The gold standard for identifying sickhealthy population is biopsy proven breast cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None